arrow
M

Martin C. Burke

CorVita Science Foundation
H指数:40
被引数:6,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LB-525395-01 A RANDOMIZED COMPARISON OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION WITH OR WITHOUT DEFIBRILLATION TESTING: THE PRIMARY RESULTS OF THE PRAETORIAN-DFT TRIAL

LB-525395-01:皮下植入式心脏转复除颤器植入术有或无除颤测试的随机比较:PRAETORIAN-DFT试验的主要结果

2026-04-160
PRE
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial

皮下植入式心律转复除颤器植入后的疼痛:PRAETORIAN-DFT试验的二次分析

2025-03-310
OAAI
Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing

评估一种第二代肋间血管外植入式心律转复除颤器电极,该电极与胸壁脉冲发生器配合用于感知、除颤和抗心动过速起搏。

2025-03-030
PRE
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial
2024-12-010
PRE
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial

皮下或经静脉植入式心脏复律除颤器患者的生活质量: PRAETORIAN试验的二次分析

2024-11-010
PRE
Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial

PRAETORIAN评分对皮下ICD患者除颤试验成功的预测价值: PRAETORIAN-DFT试验的子分析

2024-06-012
OA
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial

皮下与经静脉ICD的器械相关并发症: PRAETORIAN试验的二次分析

2022-10-0632
OAAI
A systematic scoping review of interventions to integrate physical and mental healthcare for people with serious mental illness and substance use disorders

对严重精神疾病和物质使用障碍患者的身心保健干预措施进行系统的范围界定审查

2020-09-0116
PREAI
Subcutaneous or Transvenous Defibrillator Therapy
2020-08-06278
OAAI